ResMed | RMD - 营业利润

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 33.2B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	营业利润	更改		日
Ansell	USD 146.5M		87.85M	2025-12
Artivion	USD 4.79M		6.85M	2025-12
AtriCure	USD 9.66M		9.14M	2026-06
Baxter International	USD 276M		210M	2026-06
Cochlear	AUD 261.1M		135.55M	2025-12
Cooper Companies	USD -31M		243.8M	2026-03
CSL	USD 2.64B		1.97B	2025-12
Dexcom	USD 318.3M		63M	2026-06
Edwards Lifesciences	USD 519.5M		4.8M	2026-06
Fisher Paykel Healthcare	NZD 368.8M		70.6M	2026-06
Globus Medical	USD -45.97M		209.97M	2026-06
Haemonetics	USD 57.46M		5.12M	2026-06
Idexx Laboratories	USD 425.57M		62.98M	2026-06
Inogen	USD -7.79M		728K	2024-09
Insulet	USD 129.7M		7.7M	2026-06
Integra LifeSciences	USD 41.29M		29.82M	2026-06
Intuitive Surgical	USD 977.6M		117.9M	2026-06
Medtronic	USD 2.09B		354M	2026-03
Philips	EUR 610M		308M	2026-06
Ramsay Health Care	AUD 541.1M		3.9M	2025-12
ResMed	USD 454.34M		51.33M	2026-06
Sigma Healthcare	AUD 809K		13.76M	2024-12
Sonic Healthcare	AUD 435.76M		193.66M	2024-12
Steris	USD 285.8M		32.9M	2026-06
Teleflex	USD 73.07M		36.04M	2026-06
Thermo Fisher Scientific	USD 2.18B		273M	2026-06